Relmada Therapeutics Inc (NASDAQ: RLMD) is -28.12% lower on its value in year-to-date trading and has touched a low of $0.34 and a high of $7.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RLMD stock was last observed hovering at around $0.38 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.37, the stock is -8.69% and -74.62% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing -1.66% at the moment leaves the stock -87.24% off its SMA200. RLMD registered -88.67% loss for a year compared to 6-month loss of -90.78%. The firm has a 50-day simple moving average (SMA 50) of $1.47266 and a 200-day simple moving average (SMA200) of $2.930565.
The stock witnessed a -3.86% gain in the last 1 month and extending the period to 3 months gives it a -89.32%, and is -9.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.21% over the week and 12.60% over the month.
Relmada Therapeutics Inc (RLMD) has around 20 employees, a market worth around $11.28M and $0.00M in sales. Distance from 52-week low is 9.43% and -94.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-181.60%).
The EPS is expected to grow by 16.46% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Relmada Therapeutics Inc (RLMD) Top Institutional Holders
92.0 institutions hold shares in Relmada Therapeutics Inc (RLMD), with institutional investors hold 50.09% of the company’s shares. The shares outstanding are 30.17M, and float is at 25.28M with Short Float at 6.51%. Institutions hold 46.06% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.26 million shares valued at $3.77 million. The investor’s holdings represent 4.1706% of the RLMD Shares outstanding. As of 2024-06-30, the second largest holder is DEEP TRACK CAPITAL, LP with 1.23 million shares valued at $3.7 million to account for 4.0979 of the shares outstanding. The other top investors are VESTAL POINT CAPITAL, LP which holds 1.2 million shares representing 3.9825% and valued at over $3.6 million, while ACADIAN ASSET MANAGEMENT LLC holds 3.9603 of the shares totaling 1.19 million with a market value of $3.58 million.
Relmada Therapeutics Inc (RLMD) Insider Activity
The most recent transaction is an insider purchase by TRAVERSA SERGIO, the company’s Chief Executive Officer. SEC filings show that TRAVERSA SERGIO bought 51,407 shares of the company’s common stock on Sep 11 ’24 at a price of $2.99 per share for a total of $0.15 million. Following the purchase, the insider now owns 0.38 million shares.
Relmada Therapeutics Inc disclosed in a document filed with the SEC on Sep 09 ’24 that TRAVERSA SERGIO (Chief Executive Officer) bought a total of 55,579 shares of the company’s common stock. The trade occurred on Sep 09 ’24 and was made at $2.71 per share for $0.15 million. Following the transaction, the insider now directly holds 0.3 million shares of the RLMD stock.
Still, SEC filings show that on Sep 10 ’24, TRAVERSA SERGIO (Chief Executive Officer) acquired 33,014 shares at an average price of $2.75 for $90788.0. The insider now directly holds 332,617 shares of Relmada Therapeutics Inc (RLMD).
